Labcorp Holdings Inc. (LH) stock
LHNYSEServices-Medical LaboratoriesFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 30, 2026Score 11/3016% above fair value
$370.78+2.54 (+0.69%)
Close on Nov 18, 2026Market cap $30.11BP/E 30.4Yield 0.78%
Labcorp operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
Labcorp's operating cash flow for the twelve months ending Sep 30, 2026 was $1.82B, up 0.6% year over year. For fiscal 2025 it was $1.64B, up 3.4% from the year before. Over ten years it grew 5.3% a year on average. The highest annual figure on record is $3.11B in fiscal 2021.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.64B | +3.4% |
| FY2024 | Dec 31, 2024 | $1.59B | +19.4% |
| FY2023 | Dec 31, 2023 | $1.33B | -32.1% |
| FY2022 | Dec 31, 2022 | $1.96B | -37.1% |
| FY2021 | Dec 31, 2021 | $3.11B | +45.6% |
| FY2020 | Dec 31, 2020 | $2.14B | +47.8% |
| FY2019 | Dec 31, 2019 | $1.44B | +10.7% |
| FY2018 | Dec 31, 2018 | $1.31B | -12.9% |
| FY2017 | Dec 31, 2017 | $1.50B | +25.1% |
| FY2016 | Dec 31, 2016 | $1.20B | +21.9% |
| FY2015 | Dec 31, 2015 | $982.40M | +32.9% |
| FY2014 | Dec 31, 2014 | $739.00M | -9.7% |
| FY2013 | Dec 31, 2013 | $818.70M | -2.7% |
| FY2012 | Dec 31, 2012 | $841.40M | -1.7% |
| FY2011 | Dec 31, 2011 | $855.60M | -3.2% |
| FY2010 | Dec 31, 2010 | $883.60M | +2.5% |
| FY2009 | Dec 31, 2009 | $862.40M | +10.4% |
| FY2008 | Dec 31, 2008 | $780.90M | +10.0% |
| FY2007 | Dec 31, 2007 | $709.70M | – |
Quarterly operating cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $563.80M | +45.6% |
| Q2 FY2026 | Jun 30, 2026 | $445.50M | -28.2% |
| Q1 FY2026 | Mar 31, 2026 | $191.50M | +935.1% |
| Q4 FY2025 | Dec 31, 2025 | $614.20M | -21.0% |
| Q3 FY2025 | Sep 30, 2025 | $387.20M | +39.6% |
| Q2 FY2025 | Jun 30, 2025 | $620.60M | +10.6% |
| Q1 FY2025 | Mar 31, 2025 | $18.50M | – |
| Q4 FY2024 | Dec 31, 2024 | $777.20M | +34.1% |
| Q3 FY2024 | Sep 30, 2024 | $277.30M | +0.7% |
| Q2 FY2024 | Jun 30, 2024 | $561.10M | +59.7% |
| Q1 FY2024 | Mar 31, 2024 | -$29.80M | -124.6% |
| Q4 FY2023 | Dec 31, 2023 | $579.60M | -11.3% |
| Q3 FY2023 | Sep 30, 2023 | $275.50M | -26.3% |
| Q2 FY2023 | Jun 30, 2023 | $351.40M | -38.6% |
| Q1 FY2023 | Mar 31, 2023 | $121.20M | -66.0% |
| Q4 FY2022 | Dec 31, 2022 | $653.60M | -6.3% |
| Q3 FY2022 | Sep 30, 2022 | $373.80M | -51.3% |
| Q2 FY2022 | Jun 30, 2022 | $572.50M | +17.5% |
| Q1 FY2022 | Mar 31, 2022 | $356.00M | -69.2% |
| Q4 FY2021 | Dec 31, 2021 | $697.50M | -10.0% |
| Q3 FY2021 | Sep 30, 2021 | $767.30M | -2.4% |
| Q2 FY2021 | Jun 30, 2021 | $487.20M | +31.4% |
| Q1 FY2021 | Mar 31, 2021 | $1.16B | +468.0% |
| Q4 FY2020 | Dec 31, 2020 | $774.60M | +35.9% |
| Q3 FY2020 | Sep 30, 2020 | $786.20M | +72.6% |
| Q2 FY2020 | Jun 30, 2020 | $370.70M | +46.2% |
| Q1 FY2020 | Mar 31, 2020 | $203.80M | +22.9% |
| Q4 FY2019 | Dec 31, 2019 | $569.80M | +17.1% |
| Q3 FY2019 | Sep 30, 2019 | $455.60M | +80.9% |
| Q2 FY2019 | Jun 30, 2019 | $253.50M | -34.6% |
| Q1 FY2019 | Mar 31, 2019 | $165.80M | -7.7% |
| Q4 FY2018 | Dec 31, 2018 | $486.40M | -13.9% |
| Q3 FY2018 | Sep 30, 2018 | $251.90M | -36.5% |
| Q2 FY2018 | Jun 30, 2018 | $387.40M | +24.8% |
| Q1 FY2018 | Mar 31, 2018 | $179.70M | -20.5% |
| Q4 FY2017 | Dec 31, 2017 | $565.00M | +20.2% |
| Q3 FY2017 | Sep 30, 2017 | $396.70M | – |
| Q2 FY2017 | Jun 30, 2017 | $310.50M | – |
| Q1 FY2017 | Mar 31, 2017 | $225.90M | – |
| Q4 FY2016 | Dec 31, 2016 | $470.10M | – |
See a number that looks wrong?